| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.081 | 0.01 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.01 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.45 | 0.01 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | 0.36 | 0.01 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.071 | 0.02 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.02 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.02 |